Parallel Advisors, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$101,446,294
+22.3%
3,723,483
-0.1%
3.38%
+26.6%
Q2 2023$82,916,071
+2.8%
3,726,565
+0.1%
2.67%
-1.8%
Q1 2023$80,674,251
+6.6%
3,724,573
-0.0%
2.72%
-17.1%
Q4 2022$75,647,926
-21.7%
3,724,664
-1.2%
3.28%
-26.3%
Q3 2022$96,649,000
+49.5%
3,769,455
+38.7%
4.45%
+49.9%
Q2 2022$64,642,000
+37.5%
2,718,328
+39.8%
2.97%
+59.1%
Q1 2022$47,014,000
+31.7%
1,944,319
+7.8%
1.86%
+40.6%
Q4 2021$35,707,000
+5.1%
1,803,382
+4.4%
1.33%
-3.3%
Q3 2021$33,986,000
-7.7%
1,726,908
+3.1%
1.37%
-12.1%
Q2 2021$36,836,000
-1.0%
1,674,357
+7.1%
1.56%
-11.2%
Q1 2021$37,207,000
-8.2%
1,563,974
+1.0%
1.76%
-20.1%
Q4 2020$40,512,000
+79.7%
1,548,616
+19.6%
2.20%
+57.6%
Q3 2020$22,538,000
-4.6%
1,294,904
-7.8%
1.40%
-9.5%
Q2 2020$23,622,000
+41.3%
1,404,445
-0.1%
1.54%
+14.0%
Q1 2020$16,716,000
-1.7%
1,405,8950.0%1.35%
+6.0%
Q4 2019$17,011,000
-5.8%
1,405,895
+10.0%
1.28%
-17.5%
Q3 2019$18,062,000
+62182.8%
1,277,851
+49048.1%
1.55%
+51466.7%
Q2 2019$29,0002,6000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders